Search

Your search keyword '"DLCO"' showing total 4,304 results

Search Constraints

Start Over You searched for: Descriptor "DLCO" Remove constraint Descriptor: "DLCO"
4,304 results on '"DLCO"'

Search Results

1. Correlation of the severity of the clinical presentation of SARS-CoV-2 pneumonia with respiratory function parameters in the post-COVID period.

2. Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up.

3. Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response.

4. Clinico-radiological and pulmonary function assessment of post-COVID-19 patients with respiratory symptoms

5. Socio-economic conditions affect health-related quality of life, during recovery from acute SARS-CoV-2 infection: Results from the VASCO study (VAriabili Socioeconomiche e COVID-19), on the "Surviving-COVID" cohort, from Bergamo (Italy).

6. Extracellular Vesicles Induce Nuclear Factor-κB Activation and Interleukin-8 Synthesis through miRNA-191-5p Contributing to Inflammatory Processes: Potential Implications in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

7. Prognostic value and predictors of the alteration of the diffusing capacity of the lungs for carbon monoxide in systemic lupus erythematosus.

8. Unveiling Silent Consequences: Impact of Pulmonary Tuberculosis on Lung Health and Functional Wellbeing after Treatment.

9. The impact of gas transfer on responses to exercise training in patients with pulmonary hypertension.

10. Clinical Correlates of a Nonplexiform Vasculopathy in Patients With a Diagnosis of Idiopathic Pulmonary Arterial Hypertension.

11. Lung Clearance Index as a Screening Parameter of Pulmonary Impairment in Patients under Immune Checkpoint Therapy: A Pilot Study.

13. Preoperative DLco and FEV1 are correlated with postoperative pulmonary complications in patients after esophagectomy

14. Pulmonary function testing in preoperative high-risk patients

15. Pulmonary function testing in preoperative high-risk patients.

16. The impact of gas transfer on responses to exercise training in patients with pulmonary hypertension

17. Pulmonary Vascular Volume by Quantitative CT in Dyspneic Smokers with Minor Emphysema

18. Clinical predictors of lung function in patients recovering from mild COVID-19.

19. VEGF-A plasma levels are associated with impaired DLCO and radiological sequelae in long COVID patients.

20. Beyond the Acute Phase: Long-Term Impact of COVID-19 on Functional Capacity and Prothrombotic Risk—A Pilot Study.

21. Osteoporosis and major fragility fractures (MOF) in sarcoidosis patients: association with disease severity.

22. The long-term effects of COVID-19 on pulmonary status and quality of life.

23. Impact of preheart transplant carbon monoxide diffusing capacity testing on post-transplant survival and pulmonary outcomes

24. Association between muscle quality index and pulmonary function in post-COVID-19 subjects

25. The diffusing capacity of the lungs for carbon monoxide - an independent predictor of interstitial lung disease in patients with rheumatoid arthritis - results of a prospective study

26. Tips for 6 Months After COVID-19 Pneumonia: Acute Inflammatory Parameters

28. The long-term effects of COVID-19 on pulmonary status and quality of life

29. Association between muscle quality index and pulmonary function in post-COVID-19 subjects.

30. Long-term efficacy of different doses of steroid in hospitalized COVID-19 patients: A prospective cohort study.

31. Persistent Endothelial Lung Damage and Impaired Diffusion Capacity in Long COVID.

32. DLCO Biologic Quality-Control Findings From a Multi-Center Global Study.

33. Tips for 6 Months After COVID-19 Pneumonia: Acute Inflammatory Parameters.

34. Interferon-β–Induced Pulmonary Arterial Hypertension Approach to Diagnosis and Clinical Monitoring

35. Respiratory disorders of post-COVID-19 syndrome

36. Lung diffusion capacity correlates with pre‐implant pulmonary hypertension and predicts outcome after LVAD implantation

37. The diffusing capacity of the lungs for carbon monoxide - an independent predictor of interstitial lung disease in patients with rheumatoid arthritis - results of a prospective study.

38. تاثیر سیکلوفسفامید خوراکی در بهبود تظاهرات پوستی و بیماری بینابینی ریه در بیماران مبتلا به اسکلروز سیستمیک یک مطالعه گذشته نگر.

39. Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value

41. Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL CO Correlate with Radiation Dosimetry and Pneumonitis Rate.

42. Lung diffusion capacity correlates with pre‐implant pulmonary hypertension and predicts outcome after LVAD implantation.

43. Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis

44. Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19

45. Clinical predictors of lung function in patients recovering from mild COVID-19

46. Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value.

47. Pulmonary Vascular Volume by Quantitative CT in Dyspneic Smokers with Minor Emphysema.

48. Association of Gas Diffusing Capacity of the Lung for Carbon Monoxide with Cardiovascular Morbidity and Survival in a Disadvantaged Clinical Population.

49. Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study

Catalog

Books, media, physical & digital resources